期刊文献+

慢性心力衰竭患者早期肾损害的临床研究 被引量:42

Early impairment of renal function in chronic heart failure and its clinical significance
原文传递
导出
摘要 目的观察慢性心力衰竭(心衰)患者尿微量蛋白变化及其与心功能的关系。方法测定25例心衰患者、22例心功能代偿的心脏病患者及20例健康对照的常规尿蛋白(UP)、血清肌酐(Cr)、尿素氮(BUN)、尿微量白蛋白(MA)、尿免疫球蛋白IgG(UIgG)、尿视黄醇结合蛋白(URbp)、尿β2微球蛋白(Uβ2MG)水平,并与左室射血分数(EF)等进行相关分析。结果UP、Cr、BUN正常的心衰病人MA、UIgG水平较正常对照和心功能代偿的心脏病患者明显增高[(7.49±10.47)mg/mmolCr比(1.19±0.85)mg/mmolCr和(1.63±1.62)mg/mmolCr;(0.82±1.47)mg/mmolCr比(0.27±0.15)mg/mmolCr和(0.40±0.49)mg/mmolCr;P<0.01;P<0.05],并与EF呈显著性负相关(r=-0.31,r=-0.40,P<0.01);URbp、Uβ2MG三组间差异无统计学意义。结论无原发性肾脏病变的心衰患者存在以肾小球滤过功能受损为特征的早期肾功能异常;心衰程度愈重,肾功能损伤愈明显。 Objective To observe the changs of the microproteinuria(MA) and the relationship in patients with chronic heart failure(CHF).Methods Routine urine protein, blood creatinine and urea nitrogen and MA, immunoglobulin G(UIgG), retinal-binding protein(URbp) and beta-2 -mocroglobulin(Uβ 2-MG) were measured and analyzed in 25 patients with CHF, 22 patients with cardiovascular diseases but compensated heart function s and 20 normal volunteers. Results The levels of Ualb and UIgG in the CHF group were significantly higher than those in the normal group and compensated heart function group[(7.49±10.47) mg/mmolCr vs (1.19±0.85) mg/mmolCr and (1.63±1.62) mg/mmolCr; (0.82±1.47) mg/mmolCr vs (0.27±0.15) mg/mmolCr and (0.40±0.49) mg/mmolCr; P<0.01; P<0.05; respectively] and they were negatively correlated with left ventricular ejection fraction(r=-0.31, r=-0.40, P<0.01). There were no significant difference of URbp and Uβ 2-MG among the above three groups.Conclusions There is early abnormality of renal function in CHF patients without primary renal disorder and the abnormality was featured by impaired glomerular filtration function. The more severe the heart failure, the more significant the renal function impairment.
出处 《中华内科杂志》 CAS CSCD 北大核心 2005年第4期262-264,共3页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献7

  • 1Marenzi G, Lauri G, Guazzi M, et al. Cardiac and renal dysfunction in chronic heart failure: relation to neurohumoral activation and prognosis. Am J Med Sci,2001,321:359-366.
  • 2Marczewski KT, Krawczyk W, Ryszard, et al. Particular fractions of microproteinuria in patients with stabile angina pectoris and without a clinical nephropathy. Med Sci Monit,2000,6:93-95.
  • 3Pittrow D, Wittchen HU, Bramlage P, et al. Nephropathy: an overview for daily practice. Fortschr Med Orig, 2003,121 Suppl 1:39-44.
  • 4Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin Ⅱ antagonists. Kidney Int,2000,57:1803-1817.
  • 5Russo D, Pisani A, Balletta MM, et al. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis, 1999,33:851-856.
  • 6Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation,2000,102:203-210.
  • 7Smilde TD, Hillege HL, Navis G, et al. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J,2004,148:165-172.

同被引文献281

引证文献42

二级引证文献210

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部